Navigation Links
NCI grant launches clinical trials for colon cancer screening
Date:6/25/2008

EVANSTON, Ill. --- A Northwestern University biomedical engineer who has developed optical technology shown to be effective for the early detection of colon cancer has received a $7.5 million grant over five years from the National Cancer Institute to further study an instrument that potentially could become a routine colon cancer screening test and to launch large-scale clinical trials.

Colon cancer is the second-leading cause of cancer deaths in the United States; more than 50,000 Americans die each year of the disease. Colon cancer, however, can be easily treated if detected early. But no existing population-wide screening test can accurately predict the presence of the disease with adequate sensitivity.

Vadim Backman, principal investigator for the grant and professor of biomedical engineering at Northwestern's McCormick School of Engineering and Applied Science, believes the technology he has developed could lead to the first such test. A major part of the NCI grant is to validate the technology and have it ready for commercialization.

Backman is leading a diverse group of researchers from Northwestern and the four hospitals conducting the clinical trials -- Evanston Northwestern Healthcare, the University of Chicago, Stanford University and Indiana University -- to develop an inexpensive, non-invasive test for routine colon cancer screening.

In the future, it is possible that the simple test would be conducted by a primary care physician during an annual exam. Only patients with abnormal results would go on to have the more invasive and expensive colonoscopy.

The clinical trials will include two studies. The first study of 1,000 patients will be to finalize the technology to be used in the test (making sure it can be used clinically and is practical) and to define the technology's prediction rules; the second will be a double-blind study of 3,000 patients.

The screening test, which does not require bow
'/>"/>

Contact: Megan Fellman
fellman@northwestern.edu
847-491-3115
Northwestern University
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. New grants will support research in the sustainable built environment
2. UNH receives $380,000 grant to study organic dairy as closed ecosystem
3. Revolution in rain forest monitoring with MacArthur grant
4. Precourt Institute for Energy Efficiency awards first faculty research grants
5. Jefferson receives $11.6M NIH grant to study novel mechanisms of heart failure
6. UCSB receives $3.2 million stem cell grant from state
7. BIO-key(R) Granted Image Identification System Patent for Award Winning Biometric Technology
8. Grant to fund answers about St. Johns River
9. Mascoma and UT join in $26M DOE grant
10. The Alliance for Lupus Research announces 2008 grantees
11. Autism Speaks collaborates on grant with the Allen Institute for Brain Science and autism expert
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/15/2014)... 13, 2014  While we may still be a few ... in "Star Trek" to gain instant access to all that ... with smartphones and tablets for monitoring and measuring our health ... This may seem a tad Orwellian to some, but a ... of these technological opportunities into their healthcare regime. ...
(Date:11/11/2014)... , Nov. 11, 2014  Forensicon, Inc., a ... is pleased to announce the promotion of Yaniv ... of Digital Forensics. In Schiff,s new role as Director, ... team of digital forensics examiners and provide leadership within ... Photo - http://photos.prnewswire.com/prnh/20141110/157719 Schiff ...
(Date:11/7/2014)... by Dr. Debra Auguste, associate professor, biomedical engineering, ... City College of New York, have identified a ... one of the most aggressive forms of breast ... a high mortality rate owing to aggressive proliferation ... options. However, Professor Auguste,s team, discovered the overexpression ...
Breaking Biology News(10 mins):Americans May Be Ready for a Brave New World of Healthcare 2Americans May Be Ready for a Brave New World of Healthcare 3Americans May Be Ready for a Brave New World of Healthcare 4Yaniv Schiff Promoted to Director of Digital Forensics at Forensicon, Inc. 2
... have genetic evidence suggesting the antioxidant drugs currently ... the common cold can also help prevent and ... stressa culprit in driving tumor growth. ... loss of the tumor suppressor protein Caveolin-1 (Cav-1) ...
... the increasing incidence of antifungal-resistant infections, according to a ... . The essential oil shows a potent antifungal effect ... nail infections. Scientists from the University of Coimbra ... L,Hr shrub that grows in southern Portugal. The oil ...
... progressive trajectory is one of the most deeply-entrenched assumptions ... popular media by showing cavemen speaking in grunts and ... But is this assumption correct? Were the earliest ... a paper published in the latest issue of ...
Cached Biology News:Jefferson researchers provide genetic evidence that antioxidants can help treat cancer 2Jefferson researchers provide genetic evidence that antioxidants can help treat cancer 3Lavender oil has potent antifungal effect 2Earliest humans not so different from us, research suggests 2Earliest humans not so different from us, research suggests 3
(Date:11/26/2014)... November 25, 2014 Silicon Valley Electronic ... with RPM Alliance , provider of clinical research ... With the latest addition to its CRO Partnership Program, ... EDC system to India. , “We have found ... and customizable EDC platform which is both user friendly ...
(Date:11/26/2014)... Boston, MA (PRWEB) November 26, 2014 ... and collaboration company is proud to announce that Darren ... Development and Sales. Darren will drive the ... and positive customer experience. , Darren brings ... He has held key roles in channel operations, from ...
(Date:11/26/2014)... -- Theravalues Corporation annuncia con orgoglio il lancio di ... Hi Europe 2014 (dal 2 al 4 dicembre, ... curcumina con la maggiore biodisponibilità di sempre, con una ... dalle norme europee. La curcumina è un ... Curcuma longa ) che è stata associata con attività ...
(Date:11/24/2014)... 24, 2014 VolitionRx Limited (OTCQB: VNRX), ... cancer and other conditions, today announced that data from its ... for Business BioWin Day 2014, being held November 26, 2014 ... from VolitionRx,s lung cancer pilot study, the samples for which ... Universitaire (CHU) de Liege in Belgium . ...
Breaking Biology Technology:RPM Alliance Joins Clinovo’s CRO Partnership Program, Further Strengthening Its Presence in Southern California and India 2SoundConnect Appoints Director of Channel Development & Sales 2La curcumina con la maggiore biodisponibilità di sempre farà il suo debutto in Europa 2La curcumina con la maggiore biodisponibilità di sempre farà il suo debutto in Europa 3VolitionRx to Present Positive Data from Pilot Lung Cancer Study at BioWin Day 2014 2VolitionRx to Present Positive Data from Pilot Lung Cancer Study at BioWin Day 2014 3VolitionRx to Present Positive Data from Pilot Lung Cancer Study at BioWin Day 2014 4VolitionRx to Present Positive Data from Pilot Lung Cancer Study at BioWin Day 2014 5VolitionRx to Present Positive Data from Pilot Lung Cancer Study at BioWin Day 2014 6
... Switzerland, August 19 Arpida Ltd,(SIX: ARPN) announced today its financial results ... Key events 2009 to date, - Regulatory setback for ... under review, - Company restructuring completed, , ... June 2009 , CFO Harry Welten, MBA, commented: ...
... , WESTON, Fla., Aug. 19 In keeping with ... of families, America n Scientific Resources ... obtained from Safeguard Medical Technologies, LLC exclusive worldwide rights to sell ... and the Disintegrator Plus(TM). , , All ...
... , , LONDON, Aug. 19 ... the introduction of improved drugs to treat the disease. As healthcare ... companies conducting research on diabetes vaccines. If they succeed, the entire ... (Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO ) , , ...
Cached Biology Technology:Arpida Reports Interim Results For Six Months to 30 June 2009 2American Scientific Resources To Be Exclusive Seller of World's Only FDA Approved Home Needle Destruction Device 2American Scientific Resources To Be Exclusive Seller of World's Only FDA Approved Home Needle Destruction Device 3Emergence of Newer Drug Classes to Treat Diabetes and Co-morbidities Key to Market Expansion, Reveals Frost & Sullivan 2Emergence of Newer Drug Classes to Treat Diabetes and Co-morbidities Key to Market Expansion, Reveals Frost & Sullivan 3